Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-23, Stock:JNJ, The news for the past five days is as follows:
2020-11-16: NEWS1: Oil Continues Up on Latest Vaccines Positivity.NEWS2: ‘I can’t imagine this is a long-term moneymaker:’ Desk strategist on vaccine profit for pharmaceutical companies.NEWS3: 15 Largest Drug Companies in the World.NEWS4: Vaccine Hopes Push Markets To Frothy Levels: Stocks To Watch.NEWS5: Moderna, Pfizer’s potential Covid-19 vaccines are ‘encouraging’: Dr. Brian Garibaldi.NEWS6: Moderna CEO on COVID-19 vaccine effectiveness, emergency use period.NEWS7: Why Moderna’s Vaccine Win Is a Giant Leap Against Pandemics.NEWS8: J&J (JNJ) Expands BARDA Deal for COVID-19 Vaccine Development.NEWS9: COVID-19 – Moderna Delivers Even More Impressive Results.NEWS10: Pfizer (PFE) and the Headline Effect.NEWS11: Johnson & Johnson Begins Two-Dose Phase 3 Trial Of COVID-19 Vaccine.
2020-11-17: NEWS1: J&J could have data for U.S. authorization of COVID-19 vaccine by February - Reuters interview.NEWS2: Moderna Gets Wall Street Reappraisal After Its Positive Covid-19 Vaccine News.NEWS3: Tesla to Join S&P 500 Next Month as Largest-Ever New Member.NEWS4: Johnson & Johnson to Address Racial and Social Injustice Through Platform that Aims to Eliminate Health Inequities for People of Color.NEWS5: 3 Dividend Aristocrats That Could Make You Rich.
2020-11-18: NEWS1: Stocks Are on Hold. 3 Factors That Could Send Them Higher..NEWS2: 3 Surefire Stocks to Buy If the Market Crashes.NEWS3: 2 Great Dividend Stocks Whose Payouts Could Double.NEWS4: Spain authorises Phase III trial of Johnson & Johnson COVID-19 vaccine.NEWS5: 15 Largest Biotech Companies in the World.NEWS6: Johnson & Johnson (NYSE:JNJ) Is About To Go Ex-Dividend, And It Pays A 2.7% Yield.
2020-11-19: NEWS1: Alan Fournier's Top 5 Trades of the 3rd Quarter.NEWS2: COVID-19 is ‘very real,’ not a hoax: ER Doctor.NEWS3: It’s ‘extremely urgent’ Congress passes another stimulus bill to help hospitals: CEO.NEWS4: Vaccines Fight Covid, But Can They Stop the Spread?.NEWS5: COVID-19 Vaccine Update – The Numbers are Impressive but the Markets Need More.
2020-11-20: NEWS1: U.S. sees spike in daily COVID-19 cases, hospitalizations surge.NEWS2: 7 Hot Stocks to Buy Before 2021 Ushers in Change.NEWS3: Moderna, Pfizer having similar efficacies is ‘quite encouraging’: Doctor on vaccine progress.NEWS4: WHO advises against using Remdesivir to treat COVID-19.NEWS5: Johnson & Johnson ordered to pay $120 million damages in New York baby powder case.NEWS6: Is Johnson & Johnson (JNJ) a Suitable Pick for Value Investors?.NEWS7: Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More.NEWS8: Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday.NEWS9: Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna.NEWS10: Coronavirus update: Pfizer/BioNTech file for emergency vaccine use as WHO hits Gilead's remdesivir.

Answer: Decrease